Zacytuj

Figure 1

In cancer cells, factors such as oncogenes, hormones, and therapy increase the expression of sialyltransferases while decreasing the expression of sialidases (Neu). As a result, sialoglycan synthesis by sialyltransferases in the Golgi system is increased, while sialoglycan hydrolysis by sialidases in the lysosome is decreased, resulting in the accumulation of hyposialylated structures on the cell membrane. The Fas receptor’s apoptotic signalling is impaired by unusually elevated sialoglycan expression (A). The integrins hypersialylation facilitates binding to the extracellular matrix (ECM) or selectins, allowing migration/tissue invasion and metastasis formation (C), and assisting immune evasion in cancer (B) and mediating resistance to therapy (D).
In cancer cells, factors such as oncogenes, hormones, and therapy increase the expression of sialyltransferases while decreasing the expression of sialidases (Neu). As a result, sialoglycan synthesis by sialyltransferases in the Golgi system is increased, while sialoglycan hydrolysis by sialidases in the lysosome is decreased, resulting in the accumulation of hyposialylated structures on the cell membrane. The Fas receptor’s apoptotic signalling is impaired by unusually elevated sialoglycan expression (A). The integrins hypersialylation facilitates binding to the extracellular matrix (ECM) or selectins, allowing migration/tissue invasion and metastasis formation (C), and assisting immune evasion in cancer (B) and mediating resistance to therapy (D).
eISSN:
1792-362X
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology